El "mito" de la placa vulnerable

1. Go AS, Mozaffarian D, Roger VL, et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 2014; 129:e28–292.

2. Franco M, Cooper RS, Bilal U, et al. Challenges and opportunities for cardiovascular disease prevention. Am J Med 2011;124:95–102.

3. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290:891–7.

4. Young LH, Wackers FJ, Chyun DA, et al., for the DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009;

301:1547–55.

5. Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837–47.

6. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336–45.

7. Arbab-Zadeh A, Nakano M, Virmani R, et al. Acute coronary events. Circulation 2012; 125:1147–56.

8. Bentzon JF, Otsuka F, Virmani R, et al. Mechanisms of plaque formation and rupture. Circ Res 2014; 114:1852–66.

9. Ueda Y, Ogasawara N, Matsuo K, et al. Acute coronary syndrome: insight from angioscopy. Circ J 2010; 74:411–7.

10. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003; 108:1664–72.

11. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 2003; 108:1772–8.

12. Fleg JL, Stone GW, Fayad ZA, et al. Detection of high-risk atherosclerotic plaque: report of the NHLBI working group on current status and future directions. J Am Coll Cardiol Img 2012; 5: 941–55.

13. Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30:1282–92.

14. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013; 368:2004–13.

15. Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13–8.

16. Narula J, Garg P, Achenbach S, et al. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med 2008; 5 Suppl 2:S2–10.

17. National Institutes of Health. NIH Research Portfolio Online Reporting Tools (RePORT). Available at: http://report.nih.gov. Accessed December 4, 2014.

18. Hlatky MA, Douglas PS, Cook NL, et al. Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2012; 60:569–80.

19. Stone GW, Maehara A, Lansky AJ, et al., for the PROSPECT Investigators. A prospective natural history study of coronary atherosclerosis. N Engl J Med 2011; 364:226–35.

20. Calvert PA, Obaid DR, O’Sullivan M, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) study. J Am Coll Cardiol Img 2011; 4:894–901.

21. Yonetsu T, Bouma BE, Kato K, et al. Optical coherence tomography—15 years in cardiology. Circ J 2013; 77:1933–40.

22. Tian J, Ren X, Vergallo R, et al. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol 2014;63:2209–16.

23. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009; 54:49–57.

24. Maurovich-Horvat P, Hoffmann U, Vorpahl M, et al. The napkin-ring sign: CT signature of high-risk coronary plaques? J Am Coll Cardiol Img 2010; 3:440–4.

25. Otsuka K, Fukuda S, Tanaka A, et al. Napkinring sign on coronary CT angiography for the prediction of acute coronary syndrome. J Am Coll Cardiol Img 2013; 6:448–57.

26. Puchner SB, Liu T, Mayrhofer T, et al. High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of signifiant stenosis in acute chest pain: Results from the ROMICAT-II trial. J Am Coll Cardiol 2014; 64:684–92.

27. Hellings WE, Peeters W, Moll FL, et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010; 121:1941–50.

28. Saam T, Hetterich H, Hoffmann V, et al. Metaanalysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol 2013; 62:1081–91.

29. Tanaka A, Shimada K, Sano T, et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 2005; 45: 1594–9.

30. Arbustini E, Grasso M, Diegoli M, et al. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical, and biochemical study. Am J Cardiol 1991; 68:36B–50B.

31. Hudson J, McCaughey WT. Mural thrombosis and atherogenesis in coronary arteries and aorta. An investigation using antifibrin and antiplatelet sera. Atherosclerosis 1974; 19:543–53.

32. Shimamura K, Ino Y, Kubo T, et al. Difference of ruptured plaque morphology between asymptomatic coronary artery disease and non-ST elevation acute coronary syndrome patients: an optical coherence tomography study. Atherosclerosis 2014; 235:532–7.

33. Tanaka A, Imanishi T, Kitabata H, et al. Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol 2008; 102:975–9.

34.Takano M, Inami S, Ishibashi F, et al. Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions. J Am Coll Cardiol 2005; 45:652–8.

35. Hong MK, Mintz GS, Lee CW, et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 2004; 110:928–33.

36. Schoenhagen P, Stone GW, Nissen SE, et al. Coronary plaque morphology and frequency of ulceration distant from culprit lesions in patients with unstable and stable presentation. Arterioscler Thromb Vasc Biol 2003; 23:1895–900.

37. Kotani J, Mintz GS, Castagna MT, et al. Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003; 107:2889–93.

38. Cheruvu PK, Finn AV, Gardner C, et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 2007; 50:940–9.

39. Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001; 103:934–40.

40. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999; 82:265–8.

41. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002; 106:804–8.

42. Nemetz PN, Roger VL, Ransom JE, et al. Recent trends in the prevalence of coronary disease: a population-based autopsy study of non natural deaths. Arch Intern Med 2008; 168:264–70.

43. Kubo T, Maehara A, Mintz GS, et al. The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol 2010; 55:1590–7.

44. Motreff P, Rioufol G, Finet G. Seventy-four month follow-up of coronary vulnerable plaques by serial gray-scale intravascular ultrasound. Circulation 2012;126:2878–9.

45. Uemura S, Ishigami K, Soeda T, et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J 2012; 33:78–85.

46. Tian J, Dauerman H, Toma C, et al. Prevalence and characteristics of TCFA and degree of coronary artery stenosis: an OCT, IVUS, and angiographic study. J Am Coll Cardiol 2014; 64:672–80.

47. Narula J, Kovacic JC. Putting TCFA in clinical perspective. J Am Coll Cardiol 2014; 64:681–3.

48. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007; 49:1860–70.

49. Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. J Am Coll Cardio Img 2010; 3: 1229–36.

50. Yokoya K, Takatsu H, Suzuki T, et al. Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year. Circulation 1999; 100:903–9.

51. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344:563–70.

52. Cho I, Chang HJ, Sung JM, et al., for the CONFIRM Investigators. Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM registry (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry). Circulation 2012; 126: 304–13.

53. Baber U, Mehran R, Sartori S, et al. Detection and impact of subclinical coronary and carotid atherosclerosis on cardiovascular risk prediction and reclassification in asymptomatic US adults: insights from the high risk plaque BioImage study (abstr). J Am Coll Cardiol 2014; 63:A998.

54. Collins R, Armitage J, Parish S, et al., for the Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high risk conditions. Lancet 2004; 363:757–67.

55. Cannon CP, Braunwald E, McCabe CH, et al.,for the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495–504.

56. Berger JS, Brown DL, Becker RC. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med 2008; 121:43–9.

57. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172:312–9.

58. Boden WE. Mounting evidence for lack of PCI benefit in stable ischemic heart disease: what more will it take to turn the tide of treatment? Comment on “Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease.” Arch Intern Med 2012; 172:319–21.

59. Stergiopoulos K, Boden WE, Hartigan P, et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 2014; 174:232–40.

60. Tonino PA, De Bruyne B, Pijls NH, et al., for the FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360:213–24.

61. Arbab-Zadeh A. Fractional flow reserve guided percutaneous coronary intervention is not a valid concept. Circulation 2014; 129:1871–8.

62. De Bruyne B, Fearon WF, Pijls NH, et al., for the FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014; 371:1208–17.

63. Niccoli G, Stefanini GG, Capodanno D, et al. Are the culprit lesions severely stenotic? J Am Coll Cardiol Img 2013; 6:1108–14.

64. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78:1157–66.

65. Fishbein MC, Siegel RJ. How big are coronary atherosclerotic plaques that rupture? Circulation 1996; 94:2662–6.

66. Ojio S, Takatsu H, Tanaka T, et al. Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000; 102:2063–9.

67. Frobert O, van’t Veer M, Aarnoudse W, et al. Acute myocardial infarction and underlying stenosis severity. Catheter Cardiovasc Interv 2007; 70:958–65.

68. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310:1137–40.

69. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1354–63.

70. Bittencourt MS, Hulten E, Ghoshhajra B, et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging 2014; 7:282–91.

71. Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995; 92:2157–62.

72. Boogers MJ, Broersen A, van Velzen JE, et al. Automated quantification of coronary plaque with computed tomography: comparison with intravascular

ultrasound using a dedicated registration algorithm for fusion-based quantification. Eur Heart J 2012; 33:1007–16.

73. Nicholls SJ, Hsu A, Wolski K, et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol 2010; 55:2399–407.

74. Mancini GB, Hartigan PM, Shaw LJ, et al. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. J Am Coll Cardiol Intv 2014; 7:195–201.

75. Wald DS, Morris JK, Wald NJ, et al., for the PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013; 369:1115–23.

76. Kelly DJ, McCann GP, Blackman D, et al. Complete Versus Culprit-Lesion Only Primary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. Eurointervention 2013; 8:1190–8.

77. Bainey KR, Mehta SR, Lai T, et al. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Am Heart J 2014; 167:1–14.e2.

78. Complete vs Culprit-Only Revascularization to Treat Multi-Vessel Disease After Primary PCI for STEMI (COMPLETE). Available at: http://clinicaltrials.gov/ct2/show/NCT01740479. Accessed December 4, 2014.

79. van Lammeren GW, den Ruijter HM, Vrijenhoek JE, et al. Time-dependent changes in atherosclerotic plaque composition in patients undergoing carotid surgery. Circulation 2014; 129: 2269–76.

80. McDaniel MC, Eshtehardi P, Sawaya FJ, et al. Contemporary clinical applications of coronary intravascular ultrasound. J Am Coll Cardiol Intv 2011; 4:1155–67.

81. Rodriguez-Granillo GA, Rosales MA, Llaurado C, et al. Guidance of percutaneous coronary interventions by multidetector row computed tomography coronary angiography. Eurointervention 2011; 6:773–8.

82. Madhavan MV, Tarigopula M, Mintz GS, et al. Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol 2014; 63:1703–14.